Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma

This article has been corrected: In Figure 2D, the ‘shYB1-3’ panel contains an accidental overlap of the ‘shYB1-3’ panel in Figure 3B. The corrected Figure 2D, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Figure 2. Inhibition of YB-1suppresses migration of lung adenocarcinoma cells.

(A, B) Wound healing assay of lung adenocarcinoma cells in the YB-1-silenced cells (shYB1-1 and shYB1-2: YB-1-silenced A549 cells; shYB1-3 and shYB1-4: YB-1-silenced H1299 cells) and their corresponding control cells. The distance from the wound edge was calculated with corresponding summary (right panel). (C, D) Transwell assay in lung adenocarcinoma cells in the YB-1-silenced cells and their corresponding control cells. Columns were averaged from three independent experiments. ^* P < 0.05, ^*** P < 0.01, ^*** P < 0.005, two-tailed Student’s T-tests. Error bars represent mean ± s.d. Scale bars, 100 μm (A, B), 50 μm (C, D).

Original article: Oncotarget. 2017; 8:48110–48125. 48110-48125. https://doi.org/10.18632/oncotarget.18262